perplexity_thread: "https://www.perplexity.ai/search/Q-Should-I-PNzTurg1QF.8tHh830A_Dw"
initial_query: "Should I take 5 mg Rapamycin once a week? That‘s me: (A) 50 year old male (B) Moderately overweight (C) Slow vaccination response (D) High IGF1 values."
answer: |
  Considering your characteristics individually and aggregating the evidence:

  (A) Age: At 50 years old, you are at a stage where interventions for aging might be considered. Rapamycin has shown potential in extending lifespan and healthspan in animal models, particularly when started in middle age[1][2][6][7].

  (B) Weight: As someone who is moderately overweight, rapamycin could potentially influence metabolic parameters positively, as it has been shown to improve metabolic health in obese mice[6].

  (C) Vaccination Response: Rapamycin has been shown to enhance the response of effector and memory CD8+ T cells to immunization[3]. This could potentially benefit your slow vaccination response.

  (D) High IGF1: Rapamycin inhibits the IGF-1 stimulated cell motility through the PP2A pathway[4], which might be beneficial given your high IGF1 levels. However, the direct implications of this on health outcomes require careful consideration and monitoring.

  Aggregated Evidence:
  The evidence suggests that rapamycin could potentially address several of your concerns, particularly related to aging, metabolic health, immune response, and IGF-1 levels. However, rapamycin is a potent drug with significant effects on multiple biological pathways. Its use in humans for anti-aging purposes is still experimental, and most studies have been conducted in animal models. Longitudinal data in humans are limited, and the optimal dosing for anti-aging effects without significant side effects is still under investigation.

  Given the complexity of rapamycin's actions and the potential for side effects, it is crucial to approach this treatment under medical supervision. A healthcare provider can consider your complete medical history, current health status, and the latest research to make a personalized recommendation. They can also monitor for any adverse effects and adjust the treatment as necessary.

  It is recommended to consult with a healthcare provider who is knowledgeable about aging biology and the use of rapamycin in clinical settings before starting any new treatment regimen.
sources:
  - url: "https://pubmed.ncbi.nlm.nih.gov/33037985/"
    used_text: "Rapamycin has shown potential in extending lifespan and healthspan in animal models, particularly when started in middle age."
  - url: "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190242/"
    used_text: "Rapamycin could potentially influence metabolic parameters positively, as it has been shown to improve metabolic health in obese mice."
  - url: "https://www.frontiersin.org/articles/10.3389/fcimb.2021.676183/full"
    used_text: "Rapamycin has been shown to enhance the response of effector and memory CD8+ T cells to immunization."
  - url: "https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0010578"
    used_text: "Rapamycin inhibits the IGF-1 stimulated cell motility through the PP2A pathway."
  - url: "https://www.aging-us.com/article/204920/text"
    used_text: "The most popular schedule of rapamycin for longevity is 5–7 mg once a week."
  - url: "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401992/"
    used_text: "Longitudinal data in humans are limited, and the optimal dosing for anti-aging effects without significant side effects is still under investigation."
